Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-23-000748
Filing Date
2023-05-03
Accepted
2023-05-03 13:14:43
Documents
41
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K lznn_10k.htm   iXBRL 10-K 468473
2 CERTIFICATION lznn_ex311.htm EX-31.1 10335
3 CERTIFICATION lznn_ex312.htm EX-31.2 10514
4 CERTIFICATION lznn_ex321.htm EX-32.1 4420
5 CERTIFICATION lznn_ex322.htm EX-32.2 4267
11 lznn_10kimg2.jpg GRAPHIC 20316
12 lznn_10kimg3.jpg GRAPHIC 5381
13 lznn_10kimg1.jpg GRAPHIC 16385
  Complete submission text file 0001640334-23-000748.txt   1824246

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lznn-20211231.xsd EX-101.SCH 16663
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lznn-20211231_lab.xml EX-101.LAB 98609
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lznn-20211231_cal.xml EX-101.CAL 18034
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lznn-20211231_pre.xml EX-101.PRE 80052
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lznn-20211231_def.xml EX-101.DEF 24298
35 EXTRACTED XBRL INSTANCE DOCUMENT lznn_10k_htm.xml XML 138276
Mailing Address 10F., NO.341, SEC.2, WANSHOU RD. GUISHAN DIST. TAOYUAN CITY F5 333
Business Address 10F., NO.341, SEC.2, WANSHOU RD. GUISHAN DIST. TAOYUAN CITY F5 333 88633295585
Lazuriton Nano Biotechnology (U.S.A.) Inc. (Filer) CIK: 0001666178 (see all company filings)

EIN.: 371786808 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-210091 | Film No.: 23882843
SIC: 5190 Wholesale-Miscellaneous Nondurable Goods